Donate to PCRI: https://aspatients.org/donate/
For more information, visit https://aspatients.org
0:35 Diagnosed with prostate cancer in 2009 at age 57
1:26 Was the family physician involved?
2:13 What did the urologist explain?
3:15 Not typical to be referred to a counselor and support group
3:53 What type of biopsy?
4:35 What lead to decision to choice Active Surveillance?
6:22 An important discovery made at the support group meeting
7:41 How was your wife's anxiety brought down?
8:46 Value of the second support group
9:42 Watchful Waiting vs Active Surveillance
9:52 Another tool for the toolbox
11:10 First steps for Active Surveillance
11:52 What was the PSA at that time and monitoring process?
14:31 Was there a time for a second biopsy?
16:42 Did switching to Medicare make the options for selecting a doctor easier?
17:06 The importance of being your own case manager
18:35 What should a newly diagnosed patient be told?
20:23 A plan for management
21:35 Personal monitoring system
24:04 Alex's conclusions
Don't know your stage? Take the quiz: visit http://www.prostatecancerstaging.org
To learn more about prostate cancer, visit http://www.pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.